Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Optiray (ioversol) Injection
Company:  Mallinckrodt Medical, Inc.
Application No.:  020923
Approval Date: 5/28/1998


Date created: March 9, 2004

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.